“Relapse”的搜索结果，显示 211-220 项，共有 2718 项

1. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... relapsed NSCLC. Participants in both Phase 1 and 2 will be selected for treatment with \[177Lu\]Lu FAP 2286 based on \[68Ga\]Ga FAP 2286 imaging for ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... relapsed NSCLC. Participants in both Phase 1 and 2 will be selected for treatment with \[177Lu\]Lu FAP 2286 based on \[68Ga\]Ga FAP 2286 imaging for ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

9. 临床试验- 精神病科和心理科- 妙佑医疗国际

   ... relapse. Pagination 临床研究. PrevPrevious Page · Go to page 11 · Go to page 22 · Go to page 33 · Go to page 44 · NextNext Page · 妙佑医疗国际明尼苏达州罗切斯特 ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine adverse events and change in disease symptoms of ABBV-383 in adult participants with relapsed/refractory (R/R) MM.